However, as demonstrated in Figures 2(a)–2(c), tumor cells can evade immune system detection via PD-1/PD-L1, CTLA4/B7, IDO, and other pathways, resulting in treatment failure. This evidence concerns the gene CTLA4 and neoplasm.